FEN-YU TSENGChen, Szu-TahSzu-TahChenChen, Jung-FuJung-FuChenTIEN-SHANG HUANGLin, Jen-DerJen-DerLinWang, Pei-WenPei-WenWangHuey-Herng Sheu, WayneWayneHuey-Herng SheuTIEN-CHUN CHANGAcromegaly Registry Study Group2020-03-022020-03-022019-110929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/467692The objectives of this study were to evaluate the associations between clinical parameters and quality of life (QOL) of patients with acromegaly in Taiwan and to identify the impacts of hormone control, regimens, or co-morbidities on acromegalic patients' daily life.enClinical parameters; Quality of life; Taiwan acromegaly registry[SDGs]SDG3dopamine receptor stimulating agent; glucocorticoid; growth hormone; sex hormone; somatomedin C; somatostatin derivative; thyroxine; hormone; IGF1 protein, human; somatomedin C; somatostatin; acromegaly; adult; Article; cerebrovascular accident; clinical study; comorbidity; diabetes mellitus; disease association; female; growth hormone blood level; human; major clinical study; male; medical record review; oral glucose tolerance test; psychological aspect; quality of life; questionnaire; register; remission; Taiwan; acromegaly; blood; cerebrovascular disease; complication; diabetes mellitus; middle aged; psychology; register; Acromegaly; Adult; Cerebrovascular Disorders; Comorbidity; Diabetes Mellitus; Female; Hormones; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Quality of Life; Registries; Somatostatin; Surveys and Questionnaires; Taiwanjournal article10.1016/j.jfma.2019.05.007311471972-s2.0-85066092416WOS:000491128500004https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066092416&doi=10.1016%2fj.jfma.2019.05.007&partnerID=40&md5=43f377a773a8aad0013e88aea6e10679